지역사회 발생 폐렴막대균 균혈증에서 의료관련감염의 임상적, 미 생물학적 특성
Clinical and Microbiological Characteristics of Healthcare- Associated Infections in Community-Onset Klebsiella pneumoniae Bacteremia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Although healthcare-associated (HCA) Klebsiella pneumoniae bacteremia constitutes a significant proportion of community-onset infection cases, its clinical and microbiologic characteristics have yet to be described in detail. In this study, we sought to delineate the clinical differences between community-associated (CA) and HCA K. pneumoniae bacteremia. Materials and methods: A total of 240 patients infected by community-onset K. pneumoniae bacteremia were included in this study, and the data from the patients with HCA K. pneumoniae bacteremia were compared to those with the CA bacteremia. Isolates were microbiologically characterized and serotyped using a PCR method. Results: Of the total 240 patients infected with community-onset K. pneumoniae bacteremia,140 (58.3%) were defined as HCA infection cases, and the remaining 100 patients were classified as CA infections. Multivariate analysis showed that use of percutaneous tubes, occurrence of a recent surgical operation, cases of pneumonia,neutropenia and solid tumor, and prior receipt of antibiotics were all significant factors associated with HCA bacteremia infection (all P<0.05). In terms of microbiologic characteristics, ciprofloxacin resistance (12.9% [18/140] vs. 4.0% [4/100], P=0.02) and extended-spectrum β-lactamase production (12.1% [17/140] vs. 4.0% [4/100], P =0.03)were more common in HCA bacteremia than CA bacteremia, respectively. The K1 and K2 serotypes, which are considered virulent community strains, were observed to exist more frequently in CA bacteremia than in HCA bacteremia (34% [34/100] vs. 21.4%[30/140], P=0.03). The overall 30-day mortality of the study population was 17.5%(37/211), and there was a trend toward greater mortality in the HCA group than in the CA group (21.4% [27/126] vs. 11.8% [10/85]; P=0.07). Conclusions: Patients infected with HCA bacteremia accounted for a substantial proportion of all patients with community-onset K. pneumoniae bacteremia, and showed significantly different clinical and microbiological characteristics than those infected with CA bacteremia. HCA K. pneumoniae bacteremia represented a distinct subset of community-onset bacteremia characterized by antibiotic resistant pathogens, a finding which physicians should consider in providing optimal treatment of these cases.
Abstract
Background: Although healthcare-associated (HCA) Klebsiella pneumoniae bacteremia constitutes a significant proportion of community-onset infection cases, its clinical and microbiologic characteristics have yet to be described in detail. In this study, we sought to delineate the clinical differences between community-associated (CA) and HCA K. pneumoniae bacteremia. Materials and methods: A total of 240 patients infected by community-onset K. pneumoniae bacteremia were included in this study, and the data from the patients with HCA K. pneumoniae bacteremia were compared to those with the CA bacteremia. Isolates were microbiologically characterized and serotyped using a PCR method. Results: Of the total 240 patients infected with community-onset K. pneumoniae bacteremia,140 (58.3%) were defined as HCA infection cases, and the remaining 100 patients were classified as CA infections. Multivariate analysis showed that use of percutaneous tubes, occurrence of a recent surgical operation, cases of pneumonia,neutropenia and solid tumor, and prior receipt of antibiotics were all significant factors associated with HCA bacteremia infection (all P<0.05). In terms of microbiologic characteristics, ciprofloxacin resistance (12.9% [18/140] vs. 4.0% [4/100], P=0.02) and extended-spectrum β-lactamase production (12.1% [17/140] vs. 4.0% [4/100], P =0.03)were more common in HCA bacteremia than CA bacteremia, respectively. The K1 and K2 serotypes, which are considered virulent community strains, were observed to exist more frequently in CA bacteremia than in HCA bacteremia (34% [34/100] vs. 21.4%[30/140], P=0.03). The overall 30-day mortality of the study population was 17.5%(37/211), and there was a trend toward greater mortality in the HCA group than in the CA group (21.4% [27/126] vs. 11.8% [10/85]; P=0.07). Conclusions: Patients infected with HCA bacteremia accounted for a substantial proportion of all patients with community-onset K. pneumoniae bacteremia, and showed significantly different clinical and microbiological characteristics than those infected with CA bacteremia. HCA K. pneumoniae bacteremia represented a distinct subset of community-onset bacteremia characterized by antibiotic resistant pathogens, a finding which physicians should consider in providing optimal treatment of these cases.
참고문헌 (22)
- 이경원, "High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant", Yonsei Medical Journal, 47(5), pp.634~645 (2006), 연세대학교의과대학
- Nordmann P., "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria", Lancet Infect Dis, 9, pp.228~236 (2009)
- Friedman ND., "Health care--associated bloodstream infections in adults : a reason to change the accepted definition of community-acquired infections", Ann Intern Med, 137, pp.791~797 (2002)
- 김성한, "Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 48, pp.4574~4581, AMER SOC MICROBIOLOGY
- Kim BN., "Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia", J Hosp Infect, 52, pp.99~106 (2002)
- Wu HS., "Fung CP : Characteristics of healthcare-associated and communityacquired Klebsiella pneumoniae bacteremia in Taiwan", J Infect, 64, pp.162~168 (2012)
- Perl TM., "Long-term survival and function after suspected gram-negative sepsis", JAMA, 274, pp.338~345 (1995)
- Charlson ME., "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Paterson DL., "Antibiotic therapy for Klebsiella pneumoniae bacteremia : implications of production of extended-spectrum betalactamases", Clin Infect Dis, 39, pp.31~37 (2004)
- 이정아, "Epidemiology and Clinical Features of Community-Onset Bacteremia Caused by Extended-Spectrum beta-Lactamase-Producing Klebsiella pneumoniae", MICROBIAL DRUG RESISTANCE, 17, pp.267~273, MARY ANN LIEBERT INC
- Bone RC., "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Yu WL., "Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan", Clin Infect Dis, 42, pp.1351~1358 (2006)
- Shorr AF., "Healthcare-associated bloodstream infection : A distinct entity?. . Insights from a large U. S. database", Crit Care Med, 34, pp.2588~2595 (2006)
- Siegman-Igra Y., "Reappraisal of community-acquired bacteremia : a proposal of a new classification for the spectrum of acquisition of bacteremia", Clin Infect Dis, 34, pp.1431~1439 (2002)
- Cheong HS., "Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia", J Antimicrob Chemother, 60, pp.1355~1360 (2007)
- Benito N., "Health care-associated native valve endocarditis : importance of non-nosocomial acquisition", Ann Intern Med, 150, pp.586~594 (2009)
- Venditti M., "Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia", Ann Intern Med, 150, pp.19~26 (2009)
- Ha YE., "Clinical implications of healthcareassociated infection in patients with community-onset acute pyelonephritis", Scand J Infect Dis, 43, pp.587~595 (2011)
- Ibrahim EH., "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", Chest, 118, pp.146~155 (2000)
- 김성한, "Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome", Antimicrobial Agents and Chemotherapy, 49(2), pp.760~766, American Society for Microbiology
- Chung DR., "Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea", J Clin Microbiol, 46, pp.4061~4063 (2008)
- Chung DR., "Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea", J Infect, 54, pp.578~583 (2007)